NCT04473261

Efficacy of Iodine Complex Against COVID-19 Patients

Efficacy of Iodine Complex in Mild to Moderate COVID-19 Patients

• Status: Unknown
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Sohaib Ashraf · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to measure the effect of Iodine complex in treating the COVID-19 patients to clear viral load of SARS-CoV-2 along with reduction in severity of symptoms and length of hospitalization of patients with COVID-19.

Detailed description

The proposed study is a placebo-controlled, add-on, randomized trial using parallel group designs. This is a close-label and adaptive, multi-centered design with 1:1:1:1 allocation ratio and superiority framework.

Conditions

• Covid19
• SARS-CoV-2
• Corona Virus Infection

Interventions

Type	Name	Description
DRUG	Iodine Complex	Iodine Complex capsule (200mg) will be given three times a day
DRUG	Iodine Complex	Iodine Complex syrup form (40ml) will be given three times a day
DRUG	Placebo	Empty capsule will be given as placebo
DRUG	Idoine Complex	Iodine Complex spray form 2 puffs will be given three times a day

Timeline

• Start date: 2020-07-14
• Primary completion: 2021-08-15
• Completion: 2021-10-15
• First posted: 2020-07-16
• Last updated: 2021-07-07

Locations

1 site across 1 country: Pakistan